We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Neon Healthcare Ltd is recalling the specific batch mentioned in this notification as a precautionary measure.
Pharmacy, prescription-only (POM), and general sale list (GSL) medicines: apply to move your medicine to a different classification.
Field inspection reports for the Genetic Modification Inspectorate deliberate release inspection programme in England.
'Pint’ size wine stocked on Britain’s shelves for the first time ever thanks to new freedoms from leaving the European Union
Orifarm UK has informed the MHRA of an error with the Patient Information Leaflet (PIL) packaged within the parallel import packs of the specific batches of Concerta XL 18mg and 36mg prolonged release tablets mentioned in this notification.
Employment Appeal Tribunal Judgment of Judge Tayler on 12 April 2024.
Calculate nutrient budgets for developments in the catchment of Lindisfarne SPA.
UK and 40 other OSCE States regret Russia's lack of response to Vienna Mechanism of March 2024 on prison conditions in Russia.
Novartis Pharmaceuticals has informed the MHRA that the solvent (water for injections in ampoules) co-packed with the impacted batches of Simulect powder for injection, may contain glass fragments approximately 20 – 800 µm in size.
Accord Healthcare Ltd, UK has informed the MHRA about an error with the Patient Information Leaflets (PILs) that have been packaged in the batches of these products mentioned in this notification.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Fresenius Kabi Limited has informed the MHRA of an error on the infusion bag packaged into the specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex.
Check the tariff classification for agarose beads chemically modified with 10% by weight of protein A.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
How to prepare for implementation and compliance of the Safety Features Regulation.
Calculate nutrient budgets for developments in the catchment of Rostherne Mere Ramsar.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
Calculate nutrient budgets for developments in the catchment of Solent.
Information on how the CMA investigated the merger, and how you can find out more.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.